OUH - Molecular Oncology
Nasjonal Kreftsatsing Konferanse 2016 - 10.-11. mars - Anita Sveen - YouTube
132 Dr Anita Sveen - YouTube
Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer.,Oncogenesis - X-MOL
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer - Bruun - 2018 - Molecular Oncology - Wiley Online Library
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
Anita Sveen - Matindustrien
ANITA Sveen, Karmsund | person | gulesider.no
Anita SVEEN | Oslo University Hospital, Oslo
Anita SVEEN | Oslo University Hospital, Oslo
Vårt motto er å gjøre det umulige... - Oslo universitetssykehus | Facebook
CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka open
Anita SVEEN | Oslo University Hospital, Oslo
Cognitass er fotfestet i hverdagen - Cognita
kliniskeffektforskning hashtag on Twitter
OUH - OUS-research.no
Anita SVEEN | Oslo University Hospital, Oslo
Lesernes blinkskudd - Hamar Arbeiderblad
Sammen blir det bedre
ANITA SVEEN Wettre, Biri | person | gulesider.no
Anita Sveen - Institutt for klinisk medisin
Tumour-infiltrating CD8 + lymphocytes and colorectal cancer recurrence by tumour and nodal stage | British Journal of Cancer
PDF) Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
OUH - Molecular Oncology
Anita SVEEN | Oslo University Hospital, Oslo
Preclinical drug screening identifies novel stratified treatment options according to the consensus molecular subtypes of colorectal cancer - K.G. Jebsen Colorectal Cancer Research Centre
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies | Clinical Cancer Research
OUH - Molecular Oncology
OUH - News
Biomarker-guided therapy for colorectal cancer: strength in complexity.,Nature Reviews Clinical Oncology - X-MOL
